Share Price and Basic Stock Data
Last Updated: October 10, 2025, 8:56 pm
PEG Ratio | 8.00 |
---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Tata Elxsi Ltd, a prominent player in the IT Consulting & Software industry, has demonstrated a robust revenue trajectory, with sales increasing from ₹2,471 Cr in FY 2022 to ₹3,145 Cr in FY 2023. Projections suggest a continued upward trend, with expected sales of ₹3,552 Cr in FY 2024 and ₹3,729 Cr in FY 2025. This consistent growth underscores the company’s strong market position and adaptability to changing technological landscapes. Quarterly sales figures reveal an upward movement from ₹726 Cr in June 2022 to ₹882 Cr by September 2023, evidencing a compound quarterly growth rate that highlights effective business strategies and demand for its services.
Profitability and Efficiency Metrics
Tata Elxsi’s profitability metrics are commendable, with a net profit of ₹785 Cr reported in FY 2025, yielding a net profit margin of approximately 21%. The operating profit margin (OPM) has remained relatively stable around 30% over the past few quarters, although a slight dip to 26% is anticipated in FY 2025. The return on equity (ROE) stands at an impressive 29.3%, while return on capital employed (ROCE) is at 36.3%, both significantly above industry averages, indicating efficient utilization of equity and capital. The company’s interest coverage ratio is extraordinarily high at 72,264.96x, showcasing its ability to meet interest obligations comfortably, which is a positive indicator of financial health.
Balance Sheet Strength and Financial Ratios
The balance sheet of Tata Elxsi reflects a strong financial foundation, with total reserves increasing from ₹2,023 Cr in FY 2023 to ₹2,798 Cr in FY 2025. This growth in reserves, alongside relatively low borrowings of ₹196 Cr, signifies prudent capital management. The current ratio remains healthy at approximately 1.92, indicating sufficient liquidity to cover short-term liabilities. The price-to-book value ratio (P/BV) stands at 12.72x, suggesting a premium valuation in the market, but not uncommon for high-growth tech companies. Additionally, the cash conversion cycle (CCC) has improved to 95 days, which is favorable compared to the industry norm, demonstrating effective management of working capital.
Shareholding Pattern and Investor Confidence
Tata Elxsi’s shareholding pattern reflects a balanced distribution among various stakeholders, with promoters holding 43.91%, foreign institutional investors (FIIs) at 12.74%, domestic institutional investors (DIIs) at 9.79%, and the public comprising 33.54%. This diversified ownership structure enhances investor confidence, indicating a stable governance framework. Notably, FII holdings have decreased from 15.37% in September 2022 to 12.74% in March 2025, which may raise concerns regarding foreign investor sentiment. However, the steady increase in DII holdings from 3.91% to 9.79% over the same period suggests growing domestic institutional interest, further solidifying the company’s market position.
Outlook, Risks, and Final Insight
Looking ahead, Tata Elxsi is poised for continued growth, supported by robust demand for IT services and technological innovation. However, challenges such as fluctuating foreign investor confidence and potential economic slowdowns could pose risks. The company’s high valuation, reflected in the P/E ratio of 45.0, could also deter some investors if earnings growth does not meet expectations. Nonetheless, strengths such as high ROE, strong profitability metrics, and a stable balance sheet provide a solid foundation for future performance. In conclusion, while Tata Elxsi faces typical market risks, its operational strengths and strategic positioning in the IT consulting sector suggest a positive outlook for investors willing to navigate the inherent volatility of the tech landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Tata Elxsi Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
IDream Film Infrastructure Company Ltd | 2.52 Cr. | 168 | 168/93.8 | 302 | 0.00 % | % | % | 10.0 | |
I Power Solutions India Ltd | 11.9 Cr. | 20.2 | 20.2/13.7 | 7.82 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
Hypersoft Technologies Ltd | 27.8 Cr. | 65.5 | 91.6/16.7 | 26.3 | 5.69 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
Zensar Technologies Ltd | 18,162 Cr. | 799 | 985/536 | 27.0 | 179 | 1.63 % | 21.3 % | 16.4 % | 2.00 |
Sonata Software Ltd | 10,346 Cr. | 369 | 687/286 | 24.2 | 60.8 | 1.19 % | 29.1 % | 27.3 % | 1.00 |
Industry Average | 124,853.27 Cr | 915.59 | 54.02 | 165.28 | 0.76% | 20.76% | 19.06% | 6.71 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 726 | 763 | 818 | 838 | 850 | 882 | 914 | 906 | 926 | 955 | 939 | 908 | 892 |
Expenses | 488 | 537 | 571 | 588 | 599 | 618 | 644 | 645 | 674 | 689 | 693 | 701 | 705 |
Operating Profit | 238 | 227 | 247 | 250 | 251 | 264 | 270 | 261 | 252 | 266 | 247 | 208 | 187 |
OPM % | 33% | 30% | 30% | 30% | 30% | 30% | 30% | 29% | 27% | 28% | 26% | 23% | 21% |
Other Income | 10 | 19 | 19 | 26 | 22 | 31 | 35 | 34 | 32 | 64 | 40 | 43 | 38 |
Interest | 3 | 4 | 4 | 4 | 4 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 |
Depreciation | 17 | 22 | 21 | 21 | 21 | 25 | 25 | 28 | 27 | 27 | 26 | 25 | 24 |
Profit before tax | 228 | 219 | 240 | 250 | 248 | 264 | 274 | 262 | 252 | 299 | 256 | 221 | 196 |
Tax % | 19% | 20% | 19% | 19% | 24% | 24% | 25% | 25% | 27% | 23% | 22% | 22% | 26% |
Net Profit | 185 | 174 | 195 | 202 | 189 | 200 | 206 | 197 | 184 | 229 | 199 | 172 | 144 |
EPS in Rs | 29.66 | 27.98 | 31.26 | 32.36 | 30.32 | 32.12 | 33.15 | 31.62 | 29.56 | 36.84 | 31.95 | 27.68 | 23.18 |
Last Updated: August 1, 2025, 9:25 pm
Below is a detailed analysis of the quarterly data for Tata Elxsi Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 892.00 Cr.. The value appears to be declining and may need further review. It has decreased from 908.00 Cr. (Mar 2025) to 892.00 Cr., marking a decrease of 16.00 Cr..
- For Expenses, as of Jun 2025, the value is 705.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 701.00 Cr. (Mar 2025) to 705.00 Cr., marking an increase of 4.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 187.00 Cr.. The value appears to be declining and may need further review. It has decreased from 208.00 Cr. (Mar 2025) to 187.00 Cr., marking a decrease of 21.00 Cr..
- For OPM %, as of Jun 2025, the value is 21.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Mar 2025) to 21.00%, marking a decrease of 2.00%.
- For Other Income, as of Jun 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Depreciation, as of Jun 2025, the value is 24.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 196.00 Cr.. The value appears to be declining and may need further review. It has decreased from 221.00 Cr. (Mar 2025) to 196.00 Cr., marking a decrease of 25.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Mar 2025) to 26.00%, marking an increase of 4.00%.
- For Net Profit, as of Jun 2025, the value is 144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 172.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 28.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 23.18. The value appears to be declining and may need further review. It has decreased from 27.68 (Mar 2025) to 23.18, marking a decrease of 4.50.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:51 pm
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 772 | 849 | 1,075 | 1,237 | 1,386 | 1,597 | 1,610 | 1,826 | 2,471 | 3,145 | 3,552 | 3,729 | 3,695 |
Expenses | 635 | 672 | 827 | 964 | 1,039 | 1,181 | 1,266 | 1,303 | 1,704 | 2,182 | 2,505 | 2,755 | 2,787 |
Operating Profit | 137 | 177 | 248 | 274 | 347 | 416 | 344 | 524 | 767 | 962 | 1,047 | 974 | 907 |
OPM % | 18% | 21% | 23% | 22% | 25% | 26% | 21% | 29% | 31% | 31% | 29% | 26% | 25% |
Other Income | 16 | 4 | 12 | 18 | 43 | 43 | 58 | 40 | 45 | 74 | 122 | 179 | 186 |
Interest | 3 | 1 | 1 | 1 | 1 | 1 | 7 | 7 | 10 | 17 | 21 | 20 | 19 |
Depreciation | 35 | 25 | 23 | 27 | 25 | 25 | 43 | 44 | 55 | 81 | 99 | 105 | 102 |
Profit before tax | 115 | 156 | 236 | 264 | 364 | 433 | 352 | 512 | 745 | 938 | 1,049 | 1,028 | 972 |
Tax % | 35% | 34% | 34% | 34% | 34% | 33% | 27% | 28% | 26% | 19% | 24% | 24% | |
Net Profit | 75 | 103 | 155 | 175 | 240 | 290 | 256 | 368 | 550 | 755 | 792 | 785 | 745 |
EPS in Rs | 12.06 | 16.52 | 24.85 | 28.05 | 38.54 | 46.56 | 41.12 | 59.11 | 88.26 | 121.26 | 127.21 | 126.03 | 119.65 |
Dividend Payout % | 37% | 33% | 28% | 29% | 29% | 29% | 40% | 81% | 48% | 50% | 55% | 60% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 37.33% | 50.49% | 12.90% | 37.14% | 20.83% | -11.72% | 43.75% | 49.46% | 37.27% | 4.90% | -0.88% |
Change in YoY Net Profit Growth (%) | 0.00% | 13.15% | -37.58% | 24.24% | -16.31% | -32.56% | 55.47% | 5.71% | -12.18% | -32.37% | -5.78% |
Tata Elxsi Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 16% |
5 Years: | 18% |
3 Years: | 15% |
TTM: | 2% |
Compounded Profit Growth | |
---|---|
10 Years: | 23% |
5 Years: | 25% |
3 Years: | 13% |
TTM: | -5% |
Stock Price CAGR | |
---|---|
10 Years: | 19% |
5 Years: | 36% |
3 Years: | -15% |
1 Year: | -30% |
Return on Equity | |
---|---|
10 Years: | 34% |
5 Years: | 34% |
3 Years: | 34% |
Last Year: | 29% |
Last Updated: September 5, 2025, 4:05 am
Balance Sheet
Last Updated: October 10, 2025, 2:01 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 31 | 31 | 31 | 31 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 |
Reserves | 204 | 252 | 355 | 527 | 676 | 880 | 1,028 | 1,290 | 1,539 | 2,023 | 2,443 | 2,798 | 2,640 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 58 | 73 | 138 | 185 | 225 | 196 | 169 |
Other Liabilities | 152 | 182 | 214 | 158 | 207 | 201 | 241 | 291 | 430 | 493 | 457 | 529 | 584 |
Total Liabilities | 387 | 465 | 600 | 715 | 945 | 1,143 | 1,389 | 1,717 | 2,169 | 2,764 | 3,187 | 3,586 | 3,456 |
Fixed Assets | 97 | 98 | 107 | 108 | 94 | 101 | 147 | 170 | 272 | 334 | 396 | 318 | 275 |
CWIP | 13 | 3 | 2 | 1 | 2 | 0 | 1 | 7 | 22 | 7 | 2 | 2 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Assets | 277 | 364 | 491 | 607 | 848 | 1,042 | 1,241 | 1,540 | 1,876 | 2,423 | 2,789 | 3,266 | 3,181 |
Total Assets | 387 | 465 | 600 | 715 | 945 | 1,143 | 1,389 | 1,717 | 2,169 | 2,764 | 3,187 | 3,586 | 3,456 |
Below is a detailed analysis of the balance sheet data for Tata Elxsi Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 62.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 62.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,640.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,798.00 Cr. (Mar 2025) to 2,640.00 Cr., marking a decrease of 158.00 Cr..
- For Borrowings, as of Sep 2025, the value is 169.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 196.00 Cr. (Mar 2025) to 169.00 Cr., marking a decrease of 27.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 584.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 529.00 Cr. (Mar 2025) to 584.00 Cr., marking an increase of 55.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,456.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,586.00 Cr. (Mar 2025) to 3,456.00 Cr., marking a decrease of 130.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 275.00 Cr.. The value appears to be declining and may need further review. It has decreased from 318.00 Cr. (Mar 2025) to 275.00 Cr., marking a decrease of 43.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 3,181.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,266.00 Cr. (Mar 2025) to 3,181.00 Cr., marking a decrease of 85.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,456.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,586.00 Cr. (Mar 2025) to 3,456.00 Cr., marking a decrease of 130.00 Cr..
Notably, the Reserves (2,640.00 Cr.) exceed the Borrowings (169.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 137.00 | 177.00 | 248.00 | 274.00 | 347.00 | 416.00 | 286.00 | 451.00 | 629.00 | 777.00 | -224.00 | 778.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 74 | 66 | 73 | 72 | 81 | 81 | 89 | 98 | 99 | 113 | 100 | 95 |
Inventory Days | 0 | 0 | 6 | 8 | 2 | 1 | 2 | 0 | ||||
Days Payable | 205 | 212 | 244 | 202 | 162 | |||||||
Cash Conversion Cycle | 74 | 66 | 73 | 72 | 81 | -117 | -116 | 98 | -143 | -88 | -60 | 95 |
Working Capital Days | 22 | 10 | 26 | 54 | 59 | 69 | 72 | 53 | 47 | 75 | 72 | 65 |
ROCE % | 48% | 60% | 71% | 56% | 57% | 51% | 35% | 40% | 48% | 48% | 43% | 36% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Axis Long Term Equity Fund | 524,060 | 1.28 | 399.61 | 524,060 | 2025-04-22 17:25:35 | 0% |
Axis Growth Opportunities Fund | 469,451 | 3.72 | 357.97 | 469,451 | 2025-04-22 17:25:35 | 0% |
Axis Small Cap Fund | 120,509 | 0.56 | 91.89 | 120,509 | 2025-04-22 17:25:35 | 0% |
Invesco India Smallcap Fund | 76,166 | 2.02 | 58.08 | 76,166 | 2025-04-22 17:25:35 | 0% |
Invesco India Mid Cap Fund | 62,156 | 1.39 | 47.4 | 62,156 | 2025-04-22 17:25:35 | 0% |
Edelweiss Balanced Advantage Fund | 49,499 | 0.4 | 37.74 | 49,499 | 2025-04-22 17:25:35 | 0% |
Sundaram Mid Cap Fund | 48,161 | 0.43 | 36.72 | 48,161 | 2025-04-22 17:25:35 | 0% |
Sundaram Mid Cap Fund - Institutional Plan | 48,161 | 0.43 | 36.72 | 48,161 | 2025-04-22 17:25:35 | 0% |
Tata Ethical Fund - Regular Plan | 48,000 | 1.94 | 36.6 | 48,000 | 2025-04-22 17:25:35 | 0% |
Axis Special Situations Fund | 37,451 | 2.39 | 28.56 | 37,451 | 2025-04-22 17:25:35 | 0% |
Key Financial Ratios
Month | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 32.76 | 23.21 | 6.84 | 11.11 | 10.44 |
Diluted EPS (Rs.) | 32.76 | 23.21 | 6.84 | 11.11 | 10.44 |
Cash EPS (Rs.) | 40.97 | 34.44 | 14.80 | 19.02 | 15.97 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 91.02 | 75.70 | 62.68 | 61.65 | 58.57 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 91.02 | 75.70 | 62.68 | 61.65 | 58.57 |
Revenue From Operations / Share (Rs.) | 272.78 | 248.82 | 199.65 | 173.01 | 133.57 |
PBDIT / Share (Rs.) | 58.02 | 47.85 | 24.70 | 25.11 | 16.40 |
PBIT / Share (Rs.) | 49.82 | 36.62 | 17.07 | 18.53 | 10.87 |
PBT / Share (Rs.) | 49.82 | 36.03 | 10.72 | 17.78 | 10.27 |
Net Profit / Share (Rs.) | 32.76 | 23.21 | 7.18 | 12.43 | 10.44 |
NP After MI And SOA / Share (Rs.) | 32.76 | 23.21 | 6.84 | 11.11 | 10.44 |
PBDIT Margin (%) | 21.26 | 19.23 | 12.36 | 14.51 | 12.27 |
PBIT Margin (%) | 18.26 | 14.71 | 8.55 | 10.70 | 8.13 |
PBT Margin (%) | 18.26 | 14.47 | 5.36 | 10.27 | 7.68 |
Net Profit Margin (%) | 12.01 | 9.32 | 3.59 | 7.18 | 7.81 |
NP After MI And SOA Margin (%) | 12.01 | 9.32 | 3.42 | 6.42 | 7.81 |
Return on Networth / Equity (%) | 35.99 | 30.65 | 10.91 | 18.01 | 17.83 |
Return on Capital Employeed (%) | 52.72 | 46.03 | 25.97 | 28.47 | 17.75 |
Return On Assets (%) | 21.91 | 18.60 | 5.86 | 10.33 | 10.77 |
Total Debt / Equity (X) | 0.00 | 0.00 | 0.29 | 0.17 | 0.13 |
Asset Turnover Ratio (%) | 1.99 | 2.06 | 1.75 | 1.63 | 1.38 |
Current Ratio (X) | 1.92 | 1.69 | 1.19 | 1.32 | 1.35 |
Quick Ratio (X) | 1.91 | 1.69 | 1.19 | 1.32 | 1.34 |
Dividend Payout Ratio (NP) (%) | 33.57 | 38.78 | 73.06 | 63.01 | 67.03 |
Dividend Payout Ratio (CP) (%) | 26.85 | 26.13 | 34.57 | 39.55 | 43.83 |
Earning Retention Ratio (%) | 66.43 | 61.22 | 26.94 | 36.99 | 32.97 |
Cash Earning Retention Ratio (%) | 73.15 | 73.87 | 65.43 | 60.45 | 56.17 |
Interest Coverage Ratio (X) | 72264.96 | 81.56 | 19.68 | 33.62 | 27.12 |
Interest Coverage Ratio (Post Tax) (X) | 40809.36 | 40.56 | 10.79 | 17.64 | 18.27 |
Enterprise Value (Cr.) | 3473.01 | 1643.70 | 630.41 | 617.44 | 795.86 |
EV / Net Operating Revenue (X) | 4.09 | 2.12 | 1.01 | 1.15 | 1.91 |
EV / EBITDA (X) | 19.22 | 11.03 | 8.20 | 7.89 | 15.59 |
MarketCap / Net Operating Revenue (X) | 4.25 | 2.19 | 0.95 | 1.13 | 1.90 |
Retention Ratios (%) | 66.42 | 61.21 | 26.93 | 36.98 | 32.96 |
Price / BV (X) | 12.72 | 7.19 | 3.05 | 3.18 | 4.34 |
Price / Net Operating Revenue (X) | 4.25 | 2.19 | 0.95 | 1.13 | 1.90 |
EarningsYield | 0.02 | 0.04 | 0.03 | 0.05 | 0.04 |
After reviewing the key financial ratios for Tata Elxsi Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 15, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 14) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 15, the value is 32.76. This value is within the healthy range. It has increased from 23.21 (Mar 14) to 32.76, marking an increase of 9.55.
- For Diluted EPS (Rs.), as of Mar 15, the value is 32.76. This value is within the healthy range. It has increased from 23.21 (Mar 14) to 32.76, marking an increase of 9.55.
- For Cash EPS (Rs.), as of Mar 15, the value is 40.97. This value is within the healthy range. It has increased from 34.44 (Mar 14) to 40.97, marking an increase of 6.53.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 15, the value is 91.02. It has increased from 75.70 (Mar 14) to 91.02, marking an increase of 15.32.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 15, the value is 91.02. It has increased from 75.70 (Mar 14) to 91.02, marking an increase of 15.32.
- For Revenue From Operations / Share (Rs.), as of Mar 15, the value is 272.78. It has increased from 248.82 (Mar 14) to 272.78, marking an increase of 23.96.
- For PBDIT / Share (Rs.), as of Mar 15, the value is 58.02. This value is within the healthy range. It has increased from 47.85 (Mar 14) to 58.02, marking an increase of 10.17.
- For PBIT / Share (Rs.), as of Mar 15, the value is 49.82. This value is within the healthy range. It has increased from 36.62 (Mar 14) to 49.82, marking an increase of 13.20.
- For PBT / Share (Rs.), as of Mar 15, the value is 49.82. This value is within the healthy range. It has increased from 36.03 (Mar 14) to 49.82, marking an increase of 13.79.
- For Net Profit / Share (Rs.), as of Mar 15, the value is 32.76. This value is within the healthy range. It has increased from 23.21 (Mar 14) to 32.76, marking an increase of 9.55.
- For NP After MI And SOA / Share (Rs.), as of Mar 15, the value is 32.76. This value is within the healthy range. It has increased from 23.21 (Mar 14) to 32.76, marking an increase of 9.55.
- For PBDIT Margin (%), as of Mar 15, the value is 21.26. This value is within the healthy range. It has increased from 19.23 (Mar 14) to 21.26, marking an increase of 2.03.
- For PBIT Margin (%), as of Mar 15, the value is 18.26. This value is within the healthy range. It has increased from 14.71 (Mar 14) to 18.26, marking an increase of 3.55.
- For PBT Margin (%), as of Mar 15, the value is 18.26. This value is within the healthy range. It has increased from 14.47 (Mar 14) to 18.26, marking an increase of 3.79.
- For Net Profit Margin (%), as of Mar 15, the value is 12.01. This value exceeds the healthy maximum of 10. It has increased from 9.32 (Mar 14) to 12.01, marking an increase of 2.69.
- For NP After MI And SOA Margin (%), as of Mar 15, the value is 12.01. This value is within the healthy range. It has increased from 9.32 (Mar 14) to 12.01, marking an increase of 2.69.
- For Return on Networth / Equity (%), as of Mar 15, the value is 35.99. This value is within the healthy range. It has increased from 30.65 (Mar 14) to 35.99, marking an increase of 5.34.
- For Return on Capital Employeed (%), as of Mar 15, the value is 52.72. This value is within the healthy range. It has increased from 46.03 (Mar 14) to 52.72, marking an increase of 6.69.
- For Return On Assets (%), as of Mar 15, the value is 21.91. This value is within the healthy range. It has increased from 18.60 (Mar 14) to 21.91, marking an increase of 3.31.
- For Total Debt / Equity (X), as of Mar 15, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 14) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 15, the value is 1.99. It has decreased from 2.06 (Mar 14) to 1.99, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 15, the value is 1.92. This value is within the healthy range. It has increased from 1.69 (Mar 14) to 1.92, marking an increase of 0.23.
- For Quick Ratio (X), as of Mar 15, the value is 1.91. This value is within the healthy range. It has increased from 1.69 (Mar 14) to 1.91, marking an increase of 0.22.
- For Dividend Payout Ratio (NP) (%), as of Mar 15, the value is 33.57. This value is within the healthy range. It has decreased from 38.78 (Mar 14) to 33.57, marking a decrease of 5.21.
- For Dividend Payout Ratio (CP) (%), as of Mar 15, the value is 26.85. This value is within the healthy range. It has increased from 26.13 (Mar 14) to 26.85, marking an increase of 0.72.
- For Earning Retention Ratio (%), as of Mar 15, the value is 66.43. This value is within the healthy range. It has increased from 61.22 (Mar 14) to 66.43, marking an increase of 5.21.
- For Cash Earning Retention Ratio (%), as of Mar 15, the value is 73.15. This value exceeds the healthy maximum of 70. It has decreased from 73.87 (Mar 14) to 73.15, marking a decrease of 0.72.
- For Interest Coverage Ratio (X), as of Mar 15, the value is 72,264.96. This value is within the healthy range. It has increased from 81.56 (Mar 14) to 72,264.96, marking an increase of 72,183.40.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 15, the value is 40,809.36. This value is within the healthy range. It has increased from 40.56 (Mar 14) to 40,809.36, marking an increase of 40,768.80.
- For Enterprise Value (Cr.), as of Mar 15, the value is 3,473.01. It has increased from 1,643.70 (Mar 14) to 3,473.01, marking an increase of 1,829.31.
- For EV / Net Operating Revenue (X), as of Mar 15, the value is 4.09. This value exceeds the healthy maximum of 3. It has increased from 2.12 (Mar 14) to 4.09, marking an increase of 1.97.
- For EV / EBITDA (X), as of Mar 15, the value is 19.22. This value exceeds the healthy maximum of 15. It has increased from 11.03 (Mar 14) to 19.22, marking an increase of 8.19.
- For MarketCap / Net Operating Revenue (X), as of Mar 15, the value is 4.25. This value exceeds the healthy maximum of 3. It has increased from 2.19 (Mar 14) to 4.25, marking an increase of 2.06.
- For Retention Ratios (%), as of Mar 15, the value is 66.42. This value is within the healthy range. It has increased from 61.21 (Mar 14) to 66.42, marking an increase of 5.21.
- For Price / BV (X), as of Mar 15, the value is 12.72. This value exceeds the healthy maximum of 3. It has increased from 7.19 (Mar 14) to 12.72, marking an increase of 5.53.
- For Price / Net Operating Revenue (X), as of Mar 15, the value is 4.25. This value exceeds the healthy maximum of 3. It has increased from 2.19 (Mar 14) to 4.25, marking an increase of 2.06.
- For EarningsYield, as of Mar 15, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 14) to 0.02, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Tata Elxsi Ltd:
- Net Profit Margin: 12.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 52.72% (Industry Average ROCE: 19.77%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 35.99% (Industry Average ROE: 17.25%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 40809.36
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 50.2 (Industry average Stock P/E: 43.73)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.01%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
IT Consulting & Software | ITPB Road, Whitefield, Bengaluru Karnataka 560048 | investors@tataelxsi.com http://www.tataelxsi.com |
Management | |
---|---|
Name | Position Held |
Mr. N G Subramaniam | Chairman, Non Ind & Non Exe Director |
Mr. Manoj Raghavan | Managing Director & CEO |
Ms. Ashu Suyash | Ind. Non-Executive Director |
Mr. Soumitra Bhattacharya | Ind. Non-Executive Director |
Prof. Anurag Kumar | Ind. Non-Executive Director |
Mr. Ankur Verma | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Tata Elxsi Ltd?
Tata Elxsi Ltd's intrinsic value (as of 10 October 2025) is 5177.81 which is 4.26% lower the current market price of 5,408.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹33,684 Cr. market cap, FY2025-2026 high/low of 7,985/4,601, reserves of ₹2,640 Cr, and liabilities of 3,456 Cr.
What is the Market Cap of Tata Elxsi Ltd?
The Market Cap of Tata Elxsi Ltd is 33,684 Cr..
What is the current Stock Price of Tata Elxsi Ltd as on 10 October 2025?
The current stock price of Tata Elxsi Ltd as on 10 October 2025 is 5,408.
What is the High / Low of Tata Elxsi Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Tata Elxsi Ltd stocks is 7,985/4,601.
What is the Stock P/E of Tata Elxsi Ltd?
The Stock P/E of Tata Elxsi Ltd is 50.2.
What is the Book Value of Tata Elxsi Ltd?
The Book Value of Tata Elxsi Ltd is 434.
What is the Dividend Yield of Tata Elxsi Ltd?
The Dividend Yield of Tata Elxsi Ltd is 1.39 %.
What is the ROCE of Tata Elxsi Ltd?
The ROCE of Tata Elxsi Ltd is 36.3 %.
What is the ROE of Tata Elxsi Ltd?
The ROE of Tata Elxsi Ltd is 29.3 %.
What is the Face Value of Tata Elxsi Ltd?
The Face Value of Tata Elxsi Ltd is 10.0.